Hypoxia, Receptor for Advanced Glycation End Products, and Cystic Fibrosis: A Pathway to Chronic Inflammation?

Francesca Santilli, Natale Vazzana, Loredana Bucciarelli, Giovanni Davi, Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Current Medicinal Chemistry. ,vol. 16, pp. 940- 952 ,(2009) , 10.2174/092986709787581888

Rossana G. Iannitti, Andrea Casagrande, Antonella De Luca, Cristina Cunha, Guglielmo Sorci, Francesca Riuzzi, Monica Borghi, Claudia Galosi, Cristina Massi-Benedetti, Tim D. Oury, Lisa Cariani, Maria Russo, Luigi Porcaro, Carla Colombo, Fabio Majo, Vincenzina Lucidi, Ersilia Fiscarelli, Gabriella Ricciotti, Cornelia Lass-Flörl, Luigi Ratclif, Antonella Esposito, Fernando Maria De Benedictis, Rosario Donato, Agostinho Carvalho, Luigina Romani, Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine. ,vol. 188, pp. 1338- 1350 ,(2013) , 10.1164/RCCM.201305-0986OC

Christopher H. Goss, Felix Ratjen, Update in cystic fibrosis 2012. American Journal of Respiratory and Critical Care Medicine. ,vol. 187, pp. 915- 919 ,(2013) , 10.1164/RCCM.201301-0184UP

L Zhou, C. Dey, S. Wert, M. DuVall, R. Frizzell, J. Whitsett, Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. ,vol. 266, pp. 1705- 1708 ,(1994) , 10.1126/SCIENCE.7527588

Wen Zheng, Johannes Kuhlicke, Kristian Jäckel, Holger K. Eltzschig, Anurag Singh, Markus Sjoblöm, Brigitte Riederer, Cornelia Weinhold, Ursula Seidler, Sean P. Colgan, Jorn Karhausen, Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium The FASEB Journal. ,vol. 23, pp. 204- 213 ,(2009) , 10.1096/FJ.08-110221

Claire Legendre, Marlies J. Mooij, Claire Adams, Fergal O'Gara, Impaired expression of hypoxia-inducible factor-1α in cystic fibrosis airway epithelial cells – A role for HIF-1 in the pathophysiology of CF? Journal of Cystic Fibrosis. ,vol. 10, pp. 286- 290 ,(2011) , 10.1016/J.JCF.2011.02.005

Larissa A. Shimoda, Gregg L. Semenza, HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 183, pp. 152- 156 ,(2011) , 10.1164/RCCM.201009-1393PP

Mei Yee Koh, Garth Powis, Passing the baton: the HIF switch Trends in Biochemical Sciences. ,vol. 37, pp. 364- 372 ,(2012) , 10.1016/J.TIBS.2012.06.004

Weidun Alan Guo, Paul R. Knight, Krishnan Raghavendran, The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome Intensive Care Medicine. ,vol. 38, pp. 1588- 1598 ,(2012) , 10.1007/S00134-012-2624-Y

Julie Beucher, Pierre-Yves Boëlle, Pierre-François Busson, Céline Muselet-Charlier, Annick Clement, Harriet Corvol, , AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis PLoS ONE. ,vol. 7, pp. e41913- ,(2012) , 10.1371/JOURNAL.PONE.0041913